IP Library Granted Patent US 8,153,154
Granted Patent B2
US 8,153,154 · App. 12/370,515 · Granted Apr 10, 2012

Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery systems

Assignee: University of Utah
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,153,154
App. No.
12/370,515
Granted
Apr 10, 2012
Kind
B2
Abstract

An arginine-grafted bioreducible poly(disulfide amine) (“ABP”) as a reagent for efficient and nontoxic gene delivery is described. ABP forms positively charged nano-particles of less than 200 nm with plasmid DNA. ABP is biodegraded under reducing conditions, such as the cytoplasm. ABP exhibits much higher transfection efficiency than polyethyleneimine in mammalian cells and exhibits no cytotoxicity.

Claims (12)

1. A gene delivery carrier comprising an arginine-grafted bioreducible polymer, wherein the gene delivery carrier is represented by the formula

wherein n is about 1 to about 1000; R 1 is (CH 2 ) m NH, wherein m is about 1 to about 18; and R 2 is an arginine residue.

2. The composition of claim 1 wherein R 1 is (CH 2 ) 6 NH.

3. The composition of claim 1 wherein R 1 is (CH 2 ) 4 NH.

4. The composition of claim 1 wherein R 1 is (CH 2 ) 2 NH.

5. A complex comprising a selected nucleic acid bonded to an arginine-grafted bioreducible polymer, wherein the arginine-grafted bioreducible polymer is represented by the formula

wherein n is about 1 to about 1000; R 1 is (CH 2 ) m NH, wherein m is about 1 to about 18; and R 2 is an arginine residue.

6. The complex of claim 5 wherein R 1 is (CH 2 ) 6 NH.

7. The complex of claim 5 wherein R 1 is (CH 2 ) 4 NH.

8. The complex of claim 5 wherein R 1 is (CH 2 ) 2 NH.

9. The complex of claim 5 wherein the selected nucleic acid comprises a plasmid.

10. The complex of claim 5 wherein the selected nucleic acid comprises an oligonucleotide.

Assignments (3)
CONFIRMATORY LICENSE Recorded May 11, 2015
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035624/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2009
From: KIM, SUNG WAN; KIM, TAE-IL
To: UNIVERSITY OF UTAH
Reel/Frame 022769/0777 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2009
From: UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 022769/0803 →
Continuity (2)
Provisional Application 61028131 · Feb 12, 2008
Related Publication 20090233365A1 · Sep 17, 2009